Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 632-636

  Efstathiou, Stamatis P ^a   Skeva, Irini I ^a   Dimas, Cleanthi ^b   Panagiotou, Anna ^b   Parisi, Kleo ^b   Tzanoumis, Labros ^a   Kafouri, Anna ^a   Bakratsas, Konstantinos ^a   Mountokalakis, Theodore D ^a  

^a Department of Pathology   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adiponectin; Cessation; Smoking; Tobacco

Indexed keywords

ADIPONECTIN; AMFEBUTAMONE; COTININE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG DOSE TITRATION; EVENING DOSAGE; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SMOKING CESSATION; SUSTAINED RELEASE FORMULATION; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; BUPROPION; DOPAMINE UPTAKE INHIBITORS; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 67651183648     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.022     Document Type: Article

References (25)

1. Bełtowski J., Jamroz-Wiśniewska A., and Widomska S. Adiponectin and its role in cardiovascular diseases. Cardiovasc Hematol Disord Drug Targets 8 (2008) 7-46
2. Thamer C., Stefan N., Stumvoll M., Häring H., and Fritsche A. Reduced adiponectin serum levels in smokers. Atherosclerosis 179 (2005) 421-422
3. Iwashima Y., Katsuya T., Ishikawa K., et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension 45 (2005) 1094-1100
4. Tsukinoki R., Morimoto K., and Nakayama K. Association between lifestyle factors and plasma adiponectin levels in Japanese men. Lipids Health Dis 4 (2005) 27
5. Abbasi F., Farin H.M., Lamendola C., et al. The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. J Clin Endocrinol Metab 91 (2006) 5002-5007
6. Takefuji S., Yatsuya H., Tamakoshi K., et al. Smoking status and adiponectin in healthy Japanese men and women. Prev Med 45 (2007) 471-475
7. Al Mutairi S.S., Mojiminiyi O.A., Shihab-Eldeen A.A., Al Sharafi A., and Abdella N. Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects. Ann Nutr Metab 52 (2008) 329-334
8. Sull J.W., Kim H.J., Yun J.E., Park E.J., Kim G., and Jee S.H. Serum adiponectin is associated with smoking status in healthy Korean men. Endocr J 56 (2009) 73-78
9. Miyazaki T., Shimada K., Mokuno H., and Daida H. Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease. Heart 89 (2003) 663
10. Kim O.Y., Koh S.J., Jang Y., et al. Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: cross-sectional analysis. Clin Chim Acta 370 (2006) 63-71
11. Patel J.V., Abraheem A., Dotsenko O., et al. Circulating serum adiponectin levels in patients with coronary artery disease: relationship to atherosclerotic burden and cardiac function. J Intern Med 264 (2008) 593-598
12. West R. Bupropion SR for smoking cessation. Expert Opin Pharmacother 4 (2003) 533-540
13. Fagerström K.O., and Schneider N.G. Measuring nicotine dependence: a review of the Fagerström Tolerance Questionnaire. J Behav Med 12 (1989) 159-182
14. Brinkman G.L., and Coates O. The effect of bronchitis, smoking and occupation on ventilation. Ann Rev Respir Dis 87 (1963) 68-93
15. Society for Research on Nicotine Tobacco (SRNT) Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4 (2002) 149-159
16. Isobe T., Saitoh S., Takagi S., et al. Influence of gender, age and renal function on plasma adiponectin level: the Tanno and Sobetsu study. Eur J Endocrinol 153 (2005) 91-98
17. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
18. Facchini F.S., Hollenbeck C.B., Jeppesen J., Chen Y.D., and Reaven G.M. Insulin resistance and cigarette smoking. Lancet 339 (1992) 1128-1130
19. Ahonen T.M., Kautiainen H.J., Keinänen-Kiukaanniemi S.M., Kumpusalo E.A., and Vanhala M.J. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. Am J Prev Med 35 (2008) 598-601
20. Ellis J.A., Perl S.B., Davis K., and Vichinsky L. Gender differences in smoking and cessation behaviors among young adults after implementation of local comprehensive tobacco control. Am J Public Health 98 (2008) 310-316
21. Andersson K., and Arner P. Systemic nicotine stimulates human adipose tissue lipolysis through local cholinergic and catecholaminergic receptors. Int J Obes Relat Metab Disord 25 (2001) 1225-1232
22. Fasshauer M., Klein J., Neumann S., Eszlinger M., and Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 507 (2001) 142-146
23. Okamoto Y., Arita Y., Nishida M., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32 (2000) 47-50
24. Benowitz N.L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18 (1996) 188-204
25. Tracy R.P., Psaty B.M., Macy E., et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17 (1997) 2167-2176